According to a new report from Intel Market Research, the global Eletriptan market was valued at USD 101 million in 2024 and is projected to reach USD 136 million by 2034, growing at a steady CAGR of 4.4% during the forecast period (2025-2034). This growth is fueled by the increasing global prevalence of migraine disorders, growing demand for effective acute migraine treatments, and the...